Pharmathene Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 13 Calls Today's Calls

Call Details Pharmathene Earnings Conference Call (Q1 2008) Tue, May 13, 2008, 4:30 pm Eastern Listen to the archived event audio About Pharmathene (AMEX:PIP) PharmAthene, Inc., a biodefense company, develops medical countermeasures to prevent and treat morbidity and mortality associated with the use of biological and chemical weapons in the United States. The company’s lead programs include Valortim for the prevention and treatment of anthrax infection; and Protexia for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. Its portfolio also includes a recombinant Protective Antigen (rPA) anthrax vaccine; a recombinant dual antigen Plague vaccine manufactured in E coli; and an rPA anthrax vaccine program. The company was founded in 2001 and is headquartered in Annapolis, Maryland. More Info: Quote | Profile | Reports | Research | Insider | Financials